Objective KL-6is reported to be excreted from the lung alveolar and bronchial epithelial cells and maybe a good marker for monitoring disease activity of interstitial pneumonia. This study was designed to ascertain the clinical significance of serum KL-6 levels in interstitial pneumonia associated with anti-neutrophil cytoplasmic antibody (ANCA)-related vasculitis. Methods Serum KL-6 levels were determined by an enzyme-linked immunosorbent assay. Patients We examined 20 healthy subjects, 13 patients with perinuclear (myeloperoxidase, MPO)ANCA-related vasculitis and 12 dermatomyositis (DM)/polymyositis (PM) patients as disease controls in this study. Six out of 13 patients with ANCA-related vasculitis had interstitial pneumonia.
Introduction
Interstitial pneumonia is a life threatening disease, and often immunosuppressive therapy including methylprednisolone pulse therapy is necessary ( 1) . Clinical monitoring systems for disease activity, therefore, are needed for patients with interstitial pneumonia. KL-6, MUC1mucin, is expressed on type II alveolar pneumocytes and bronchial epithelial cells (2) . Recent studies have revealed that serum levels of KL-6 reflect the disease activity of interstitial pneumonia and serve as a useful clinical marker (3) (4) (5) (6) (7) . Perinuclear anti-neutrophil cytoplasmic antibody (ANCA)-related vasculitis, whose antigen is myeloperoxidase (MPO), often affects the lung as well as the kidney. Recent studies have revealed the molecular mechanisms and pathogenesis in interstitial pneumonia followed by the presence of ANCA.Circulating ANCAattaches to the primed neutrophil surface and destroys the neutrophilic cell membrane,leading to the subsequent release of intracytoplasmic toxic products with resultant matrix and endothelial injury. Then, neutrophils accumulate in an intact interstitial space and undergo oxidative burst, resulting in the destruction of the alveolar wall (8) . Based on these types of injury, pulmonary lesions associated with ANCAinclude pulmonary capillaritis, alveolar hemorrhage and lung fibrosis, all of which show a poor prognosis despite immunosuppressive therapy (9) (10) (11) (12) . Therefore, the development of a clinical monitoring system for diagnosis and as a means to monitor the disease activity of interstitial pneumonia in patients with ANCA-related vasculitis seems necessary. Here, we evaluated the serum levels of KL-6 in patients with ANCA-related vasculitis to determine whether or not the KL-6 levels in sera reflect disease activity of interstitial pneumonia associated with ANCA.
Materials and Methods
Patien ts Weevaluated 1 3 patients with perinuclear ANCA-related vasculitis, proven by the presence ofANCAin serum and microscopic polyangiitis in 12 patients by kidney biopsy and in 1 patient by skin biopsy (mean age 70.1 years old, range 51 to 83 years old). Six out of 13 patients with ANCAwere affected with interstitial pneumonia (Table 1 ). Twelve patients (1 male and 1 1 females) with DM/PMwith/without interstitial pneumonia (mean age 66.3 years old, range 48 to 86 years old) were included as disease controls. In addition, 20 healthy volunteers were also included as controls (mean age 72.5 years old, range 66 to 84 years old). The diagnosis of interstitial pneumonia was based on the typical clinical findings of chest radiographs and chest computed tomography (CT), and findings in spirometory such as the diffusion capacity ( 1 1). Patients in a clinically active state were treated with glucocorticoid including methylprednisolone pulse therapy 500-1 ,000 mg/day for 3 days. Measurement of serum KL-6 levels was performed with the consent of all the patients.
KL-6 measurements
The concentration of KL-6 in sera (normal value <500 U/ ml) was detected by a sandwich type enzyme-linked immunosorbent assay (ELISA) kit (ED046; Eisai Co., Ltd., Tokyo) (3, 13) . In brief, polystyrene cups coated with KL-6 antibody were incubated with 0.1 ml of ten-fold diluted serum at 25°C for 1 hour. Then the cups were washed with 0.85% NaCl and incubated at 25°C for 1 hour with 0. 1 ml of 1,000-fold diluted horseradish peroxidase-conjugated KL-6 antibody. Next, the cups were washed again, 0.1 ml ofABTS solution (1.5 mg/ml 2,2'-azino-bis 3-ethylbenz-thiazoline-6-sulfonic acid), 0.02% H2O2, and 0.1 Mcitrate buffer at a pH of4.2 was added, and incubation was performed at 25°C for 1 hour. Finally, 0.013 M NaN3 was added to inhibit the peroxidase reaction and the absorbance at 405 nmwas measured.
MPO-ANCAmeasurements
The presence of perinuclear ANCA in circulation was determined by ELISA using microtiter plates coated with myeloperoxidase extracts (SRL Co., Tokyo), where normal values are less than 10 ElA units.
Sta tistical analysis
Data are expressed as mean±standard error. Statistical comparison of the data was carried out using the ANOVA test (StatView, Abacus Concepts, Inc., Berkeley, CA, USA). Statistical significance was defined as p< 0.05.
Results KL-6 levels in sera in patients with ANCA-related vasculitis Among1 3 patients with ANCA-related vasculitis, 6 patients suffered from interstitial pneumonia (Table 1) ; Serum levels of KL-6 in all the patients with ANCAwas 843.1±278.9 U/ml (range, 79.0-3,643.0). KL-6 levels in sera in ANCApatients with interstitial pneumonia were significantly higher than those of the patients without interstitial pneumonia and healthy subjects (1,533.7±473.8 U/ml vs. 251.1±46.6 U/ml and 212.2±24.9 U/ml, p<0.05, respectively) ( Fig. 1) . Serum levels of KL-6 in all the patients with DM/PM was l,421.9±540.9 U/ml (range, 167.0-6,638.0).
Similarly, KL-6 levels in sera in 7 DM/PM patients with interstitial pneumoniawere significantly elevated compared to those of the patients without interstitial pneumonia (1,984.6±873.8 U/ml vs. 648.6±258.9 U/ml, p<0.05, respectively).
Effects of glucocorticoid therapy on serum levels of KL-6 Serum KL-6 levels in ANCApatients with interstitial pneu- moniawere examinedin four patients after glucocorticoid therapy. Serum levels of KL-6 in 3 out of 4 ANCApatients decreased significantly during the convalescent period. However, one patient who died due to severe interstitial pneumonia showed an increase in KL-6 levels despite therapy (Figs. 2,   3A ).
A representative patient with interstitial pneumonia
An 83-year-old man was admitted to KanazawaUniversity Hospital because of renal dysfunction in February 1998 (Fig.  3A) . Serum creatinine (Cr) levels were increased from 2.3 mg/ dl to 4.9 mg/dl in accordance with the elevation of MPO-ANCA (1 17 EIA units, normal; <10 EIA units). There was no evidence of interstitial pneumonia and the serum level of KL-6 was 290 IU/ml on admission (Fig. 3B) . Glucocorticoid treatment led to the improvement of renal function and decrease of MPO-ANCA titers. However, 1 month after methylprednisolone pulse therapy, Cr was increased from 2.7 mg/dl to 6.1 mg/dl. Chest X-ray and CTshowed active interstitial pneumonia and pulmonary hemorrhage in accordance with the increase of KL-6 and MPO-ANCA titers (Fig. 3C ). In parallel with deteriorated renal function and lung lesions, KL-6 levels and MPO-ANCA increased and reached a peak at death. These data suggest that the measurementof serum levels of KL-6reflect disease activity in interstitial pneumonia. Discussion KL-6 was reported in 1989 as a serum indicator of interstitial pneumonia (2) . KL-6is expressed on type II pneumocytes and bronchial epithelial cells. KL-6is detected in sera at the time of injury such as interstitial pneumonia, berylliosis and radiation pneumonitis (3-7) . In contrast, in patients with bacterial pneumonia, bronchial asthma and chronic bronchitis, the serum levels of KL-6remain low. Therefore, the elevation of KL-6 in sera may specifically reflect lung injury. In this study, the serum levels of KL-6 were significantly higher in ANCA patients with interstitial pneumonia. In comparison, the serum levels of KL-6 in ANCApatients without interstitial pneumonia remained similar to levels in healthy subjects. These data suggest that serum levels of KL-6 were not simply reflected by the presence of ANCA. Similarly, KL-6 levels in serum were elevated in 12 DM/PMpatients with interstitial pneumonia, as disease controls, while they remained low in DM/PMpatients without interstitial pneumonia. Taken together, the elevation of serum KL-6levels was commonly observed in accordance with the disease activity of interstitial pneumonia in patients with ANCA. Therefore, it may be a good diagnostic marker of interstitial pneumonia of ANCA-related vasculitis. Wemeasured the serum levels of KL-6serially in 4 ANCA patients with interstitial pneumonia. KL-6 levels in sera decreased during the convalescence with glucocorticoid therapy in 3 patients. In contrast, 1 patient showed an increase in KL-6 levels despite the therapy and eventually died due to interstitial pneumonia and pulmonary hemorrhage. In that case, the initial KL-6 level was normal, but it became elevated before the onset of clinical symptoms and increased in accordance with the severity of lung involvement. Methylprednisolone pulse therapy and oral prednisolone treatment improved the renal function and titer ofANCA. On the other hand, the levels of KL-6 increased progressively in spite of the immunosuppressive therapy. These data suggest that KL-6 levels mayreflect the disease activity of interstitial pneumonia associated with ANCA. ANCA-relatedvasculitis often affects renal function. However, as shown in Fig. 3 , serum KL-6 levels remained low whenthe renal function was deteriorated, suggesting that serum KL-6 levels may be less affected by renal function. Collectively, the measurement of KL-6 may be a useful marker to assess the effect of therapy on interstitial pneumonia in ANCA patients even in those with renal dysfunction. It is hypothesized that continuous interstitial endothelial cell damage causes interstitial inflammation, resulting in interstitial pneumonia ( 14) . In PM/DMassociated interstitial pneumonia, it is reported that immunecomplex in alveoli maybe associated with the development of interstitial pneumonia and type III allergic reaction mayplay an important role in the pathogenesis (15, 16) . Although the detailed mechanisms of interstitial pneumonia in DM/PMand ANCA-related vasculitis may differ, the destruction of alveolar pneumocytes is followed by an increase of KL-6 in sera. In ANCA-related vasculitis, the interaction of ANCA and neutrophils may result in endothelial damage, leading to increased permeability and inflammation.
Supporting this notion, Inoue et al reported that measurements of KL-6 in the peripheral blood may reflect not only epithelial cell injury in the lung but also the degree of leakage from the alveolus to the capillary in berylliosis (7) . Therefore, the elevation of serum KL-6 levels in interstitial pneumonia in patients with ANCA-related vasculitis may also reflect both the leakage resulting from endothelial injury and the presence of epithelial injury. In addition, serum KL-6 levels may contrib- ute to the early identification of patients with a high probability of resistance to corticosteroid therapy and may predict the outcome of rapidly progressive idiopathic pulmonary fibrosis (4). Although it remains unclear whether or not KL-6 levels in serumreflect the outcomeof interstitial pneumoniaassociated with ANCA-relatedvasculitis, it is reasonable to speculate that the measurementof KL-6levels in sera maybe an indicator of disease activity of interstitial pneumonia associated with ANCA-related vasculitis.
